AML
72 Hours
QPCR
Accredited NRL Laboratory
Once a week
Monitor minimal residual disease via NPM1 mutation analysis; prognostic indicator in acute myeloid leukemia.
Peripheral blood
8 mL
Lavender-top (EDTA) tube
No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.
This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.
| Temperature | Period |
|---|---|
| Refrigerated | 2 days |